Back to Search
JACQUELINE VUKY, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1851462998IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD00039647(WA)MD154135(OR)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1995
Research & Publications (9)
Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer.
PMID 19130458·Cancer·2009
3-trial
Phase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma.
PMID 16380835·Invest New Drugs·2006
3-trial
Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma.
PMID 12201495·Invest New Drugs·2002
3-trial
Salvage chemotherapy for patients with advanced pure seminoma.
PMID 11773182·J Clin Oncol·2002
8-other
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
PMID 11157018·J Clin Oncol·2001
3-trial
Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors.
PMID 10958596·Invest New Drugs·2000
3-trial
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors.
PMID 14739666·Invest New Drugs·2004
3-trial
Phase II trial of thalidomide for patients with advanced renal cell carcinoma.
PMID 11773183·J Clin Oncol·2002
3-trial
Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma.
PMID 11230473·J Clin Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1130 NW 22ND AVE, SUITE 100
PORTLAND, OR 97210 - Phone
- (503) 299-6500
Quick Facts
- NPI
- 1851462998
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 31
- Publications
- 9
Are you this provider?
Claim Your Profile